Skip to contentI
Intelligent Bio Solutions Inc.
I
INBSIntelligent Bio Solutions Inc. Q3 2025 · 10-Q
Revenue$728.87K$728.87K−11.5% vs Q3 2024 Net Income-$2.54M-$2.54MN/M vs Q3 2024 EPS Diluted-$4.41-$4.41N/M vs Q3 2024 Gross Profit$341,368+91.3% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Intelligent Bio Solutions Inc. · CIK 1725430 · Engraved from SEC EDGAR
Operating Cash Flowderived-$2,755,388N/M Margins · derivedGross margin46.8%+25.2 pt vs Q3 2024
Operating margin-351.3%+7.3 pt vs Q3 2024
Net margin-349.0%+12.5 pt vs Q3 2024
ended Mar 31, 2025 · filed May 13, 2025 · 43 d after period end